33 results on '"Akihito Hayashi"'
Search Results
2. 10-Gingerol Suppresses Osteoclastogenesis in RAW264.7 Cells and Zebrafish Osteoporotic Scales
- Author
-
Liqing Zang, Kazuhiro Kagotani, Hiroko Nakayama, Jacky Bhagat, Yuki Fujimoto, Akihito Hayashi, Ryoji Sono, Hirotaka Katsuzaki, Norihiro Nishimura, and Yasuhito Shimada
- Subjects
bone resorption ,osteopenia ,bone regeneration ,Danio rerio ,natural product ,Biology (General) ,QH301-705.5 - Abstract
Osteoporosis is the most common aging-associated bone disease and is caused by hyperactivation of osteoclastic activity. We previously reported that the hexane extract of ginger rhizome [ginger hexane extract (GHE)] could suppress receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis in RAW264.7 cells. However, the anti-osteoclastic components in GHE have not yet been identified. In this study, we separated GHE into several fractions using silica gel column chromatography and evaluated their effects on osteoclastogenesis using a RAW264.7 cell osteoclast differentiation assay (in vitro) and the zebrafish scale model of osteoporosis (in vivo). We identified that the fractions containing 10-gingerol suppressed osteoclastogenesis in RAW264.7 cells detected by tartrate-resistant acid phosphatase (TRAP) staining. In zebrafish, GHE and 10-gingerol suppressed osteoclastogenesis in prednisolone-induced osteoporosis regenerated scales to promote normal regeneration. Gene expression analysis revealed that 10-gingerol suppressed osteoclast markers in RAW264.7 cells [osteoclast-associated immunoglobulin-like receptor, dendrocyte-expressed seven transmembrane protein, and matrix metallopeptidase-9 (Mmp9)] and zebrafish scales [osteoclast-specific cathepsin K (CTSK), mmp2, and mmp9]. Interestingly, nuclear factor of activated T-cells cytoplasmic 1, a master transcription regulator of osteoclast differentiation upstream of the osteoclastic activators, was downregulated in zebrafish scales but showed no alteration in RAW264.7 cells. In addition, 10-gingerol inhibited CTSK activity under cell-free conditions. This is the first study, to our knowledge, that has found that 10-gingerol in GHE could suppress osteoclastic activity in both in vitro and in vivo conditions.
- Published
- 2021
- Full Text
- View/download PDF
3. A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
- Author
-
Hisashi Tanaka, Kageaki Taima, Takeshi Morimoto, Yoshihito Tanaka, Masamichi Itoga, Kunihiko Nakamura, Akihito Hayashi, Mika Kumagai, Hideo Yasugahira, Megumi Mikuniya, Koichi Okudera, Shingo Takanashi, and Sadatomo Tasaka
- Subjects
Lung cancer ,Nab-paclitaxel ,Refractory ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background We aimed to evaluate the efficacy and safety of nab-paclitaxel in patients with refractory advanced non-small cell lung cancer who failed previous chemotherapy. Methods Patients were required to have an Eastern Cooperative Oncology Group performance status of 0–2 and adequate organ function. Patients received nab-paclitaxel, 100 mg/m2 i.v. on days 1, 8, and 15 every 4 weeks. The primary endpoint was the overall response rate. Secondary endpoints were the progression-free survival time, overall survival, and the toxicity profile. Results From July 2013 to July 2015, a total of 31 patients were enrolled. Fourteen patients received nab-paclitaxel as a second-line and 17 received it as an over third-line therapy. Each patient received a median of 5 treatment cycles (range, 1–11). The overall response rate was 19.3% (95% confidence interval, 9.1–36.2%) (complete response (n = 0), partial response (n = 6), stable disease (n = 17), and progressive disease (n = 8)). The median progression-free survival time was 4.5 months (95% confidence interval 3.5–6.3 months), median overall survival time was 15.7 months, and 1-year survival rate was 54.8%. Most common grade 3 or 4 non-hematological toxicities were elevated aspartate transaminase level (3.2%) and sensory neuropathy (9.6%). Neutropenia was the most common grade 3 or 4 adverse events (38.6%), and febrile neutropenia developed in 12.9% patients. No treatment-related deaths were observed in this study. Conclusion Primary endpoint was met. Single agent nab-paclitaxel showed significant clinical efficacy and manageable toxicities for patients with chemorefractory advanced non-small cell lung cancer even if late line setting. Trial registration UMIN000011696 . The date of registration was July 11th, 2013.
- Published
- 2017
- Full Text
- View/download PDF
4. Lecithin-Based Dermal Drug Delivery for Anti-Pigmentation Maize Ceramide
- Author
-
Kazuhiro Kagotani, Hiroko Nakayama, Liqing Zang, Yuki Fujimoto, Akihito Hayashi, Ryoji Sono, Norihiro Nishimura, and Yasuhito Shimada
- Subjects
zebrafish screening ,cone ceramide ,in vivo imaging ,Organic chemistry ,QD241-441 - Abstract
Ceramides have several well-known biological properties, including anti-pigmentation and anti-melanogenesis, which make them applicable for use in skincare products in cosmetics. However, the efficacy of ceramides is still limited. Dermal or transdermal drug delivery systems can enhance the anti-pigmentation properties of ceramides, although there is currently no systemic evaluation method for the efficacy of these systems. Here we prepared several types of lecithin-based emulsion of maize-derived glucosylceramide, determining PC70-ceramide (phosphatidylcholine-base) to be the safest and most effective anti-pigmentation agent using zebrafish larvae. We also demonstrated the efficacy of PC70 as a drug delivery system by showing that PC70-Nile Red (red fluorescence) promoted Nile Red accumulation in the larval bodies. In addition, PC70-ceramide suppressed melanin in mouse B16 melanoma cells compared to ceramide alone. In conclusion, we developed a lecithin-based dermal delivery method for ceramide using zebrafish larvae with implications for human clinical use.
- Published
- 2020
- Full Text
- View/download PDF
5. Clarification of the Mechanism of Inhibiting the Maillard Reaction between Phosphatidylethanolamine and Sugars by Adding Fatty Acid Calcium Salts
- Author
-
Yuki Fujimoto, Akihito Hayashi, Nobutoshi Hamaguchi, Zhihui Zhan, and Chul-Sa Kim
- Subjects
General Chemical Engineering ,General Medicine ,General Chemistry - Published
- 2023
- Full Text
- View/download PDF
6. A rare etiology of mild encephalitis/encephalopathy with reversible splenial lesion
- Author
-
Hideki Mine, Hiroki Shimono, Hiroaki Muguruma, Yoji Hoshina, Akihito Hayashi, Midori Araki, Ei Ogawa, and Akiyoshi Yamamoto
- Subjects
Pathology ,medicine.medical_specialty ,Medicine (General) ,mild encephalitis/encephalopathy with reversible splenial lesion ,Legionella ,Urinary system ,Encephalopathy ,Lesion ,Cerebrospinal fluid ,R5-920 ,Clinical Images ,medicine ,biology ,business.industry ,fungi ,food and beverages ,General Medicine ,biology.organism_classification ,medicine.disease ,Clinical Image ,Etiology ,Medicine ,medicine.symptom ,Splenial ,business ,Encephalitis - Abstract
Legionella is a rare cause of mild encephalitis/encephalopathy with reversible splenial lesion, which should be considered in patients with risk factors. Brain magnetic resonance imaging (MRI) and legionella urinary antigen test can help the diagnosis since cerebrospinal fluid (CSF) can be normal.
- Published
- 2021
7. Use of Fatty Acid Metal Salts for Preventing Maillard Reaction-Driven Browning of Lecithins
- Author
-
Yuki Fujimoto, Nobutoshi Hamaguchi, Akihito Hayashi, Chul-Sa Kim, and Zhi-Hui Zhan
- Subjects
Acid value ,Hot Temperature ,030309 nutrition & dietetics ,General Chemical Engineering ,Calcium stearate ,03 medical and health sciences ,symbols.namesake ,chemistry.chemical_compound ,0404 agricultural biotechnology ,Stearate ,Lecithins ,Magnesium stearate ,chemistry.chemical_classification ,0303 health sciences ,Chemistry ,Silicates ,Fatty Acids ,Fatty acid ,04 agricultural and veterinary sciences ,General Medicine ,General Chemistry ,Calcium Compounds ,040401 food science ,Maillard Reaction ,Maillard reaction ,Metals ,Calcium silicate ,symbols ,Sodium stearate ,Soybeans ,Nuclear chemistry - Abstract
We previously reported that fluid soybean lecithin (SL) undergoes heat deterioration by the newly reported pseudo-Maillard rearrangement reaction. To inhibit heat deterioration, SLs were treated with metal silicates, such as magnesium silicate and calcium silicate. When soybean fatty acid was added to SL before treatment with calcium silicate, the color index after heating improved significantly as the acid value increased from 10 to 35 mg KOH/g. To elucidate the role of soybean fatty acid, calcium silicate treatment was carried out by adding several fatty acids to SL. Although saturated fatty acids had no effect on the heat deterioration of SL, unsaturated fatty acids were significantly more effective at inhibiting heat deterioration. Furthermore, for unsaturated fatty acids, it was confirmed that the calcium concentration increased in SL. Based on these results, several fatty acid metal salts were added to confirm whether heat deterioration while heating SL could be inhibited. It was observed that the heat deterioration of SL could be inhibited with fatty acid metal salts, regardless of whether the fatty acids were saturated or unsaturated and whether the metal was monovalent, divalent, or trivalent. Therefore, in this study, we clarified that the heat deterioration of SL could be inhibited by adding fatty acid metal salts to SL. Among sodium stearate, calcium stearate, magnesium stearate, barium stearate, and aluminum tristearate, the divalent fatty acid metal salts had a stronger inhibitory effect on heat deterioration than the monovalent and trivalent salts.
- Published
- 2021
8. Wind : a Low-Costs Communication Module for Software DSM Systems.
- Author
-
Shoichi Saito, Akihito Hayashi, Tetsutaro Uehara, Kazuki Joe, and Yoshitoshi Kunieda
- Published
- 2000
9. Lecithin-Based Dermal Drug Delivery for Anti-Pigmentation Maize Ceramide
- Author
-
Hiroko Nakayama, Liqing Zang, Yasuhito Shimada, Ryoji Sono, Norihiro Nishimura, Akihito Hayashi, Kazuhiro Kagotani, and Yuki Fujimoto
- Subjects
Ceramide ,food.ingredient ,Melanoma, Experimental ,Pharmaceutical Science ,Skin Pigmentation ,02 engineering and technology ,Pharmacology ,Ceramides ,Lecithin ,Zea mays ,Article ,Analytical Chemistry ,Melanin ,lcsh:QD241-441 ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,food ,Drug Delivery Systems ,lcsh:Organic chemistry ,Drug Discovery ,Lecithins ,Animals ,Physical and Theoretical Chemistry ,cone ceramide ,Zebrafish ,030304 developmental biology ,Transdermal ,0303 health sciences ,Drug Carriers ,Pigmentation ,Organic Chemistry ,Nile red ,021001 nanoscience & nanotechnology ,chemistry ,Chemistry (miscellaneous) ,Emulsion ,Drug delivery ,Molecular Medicine ,in vivo imaging ,0210 nano-technology ,B16 melanoma ,zebrafish screening - Abstract
Ceramides have several well-known biological properties, including anti-pigmentation and anti-melanogenesis, which make them applicable for use in skincare products in cosmetics. However, the efficacy of ceramides is still limited. Dermal or transdermal drug delivery systems can enhance the anti-pigmentation properties of ceramides, although there is currently no systemic evaluation method for the efficacy of these systems. Here we prepared several types of lecithin-based emulsion of maize-derived glucosylceramide, determining PC70-ceramide (phosphatidylcholine-base) to be the safest and most effective anti-pigmentation agent using zebrafish larvae. We also demonstrated the efficacy of PC70 as a drug delivery system by showing that PC70-Nile Red (red fluorescence) promoted Nile Red accumulation in the larval bodies. In addition, PC70-ceramide suppressed melanin in mouse B16 melanoma cells compared to ceramide alone. In conclusion, we developed a lecithin-based dermal delivery method for ceramide using zebrafish larvae with implications for human clinical use.
- Published
- 2020
10. VERIFICATION ON ASBESTOS DISPERSAL DURING REPAIR AND REMOVAL OF ASBESTOS CONTAINING COATING MATERIALS FOR TEXTURED FINISHES OF BUILDINGS
- Author
-
Akihito Hayashi, Takayuki Fukuoka, Kenji Motohashi, Junko Koga, Yoshihito Konishi, Kenichi Mori, and Hiroyuki Miyauchi
- Subjects
Architecture ,Metallurgy ,Coating materials ,Demolition ,medicine ,Environmental science ,Biological dispersal ,Building and Construction ,medicine.disease_cause ,Asbestos - Published
- 2016
- Full Text
- View/download PDF
11. Clinical application of immunocytochemical detection of ALK rearrangement on cytology slides for detection or screening of lung adenocarcinoma
- Author
-
Akihito Hayashi, Akira Kurose, Hideyuki Nakagawa, Hisashi Tanaka, Yoshihito Tanaka, Takeshi Morimoto, Ken Okumura, Kageaki Taima, Kiyoshi Tone, and Shingo Takanashi
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,Cancer Research ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,Cytodiagnosis ,Concordance ,Immunocytochemistry ,Adenocarcinoma of Lung ,Adenocarcinoma ,Translocation, Genetic ,Bronchoscopy ,Cytology ,Humans ,Medicine ,Anaplastic lymphoma kinase ,Anaplastic Lymphoma Kinase ,Lung cancer ,In Situ Hybridization, Fluorescence ,Aged ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Receptor Protein-Tyrosine Kinases ,Middle Aged ,medicine.disease ,Immunohistochemistry ,Oncology ,Female ,business - Abstract
Immunohistochemical screening of Anaplastic lymphoma kinase (ALK) rearrangement has been regarded essential and routinely carried out to select treatment for lung adenocarcinoma. However, difficulty to approach a tumor by transbronchial lung biopsy (TBLB), it often fails to obtain tumor tissues whereas tumor cells are contained in cytology specimens simultaneously obtained when the bronchoscopy is done. Therefore we evaluated the expression of ALK protein by using immunohistochemistry (IHC) on TBLB specimens and immunocytochemistry (ICC) on brushing smear cytology slides in the same cases, and compared the concordance rate of IHC and ICC results. ICC was carried out on routine Papanicolau-stained slides after cytology diagnosis and decolorization. Results Eighteen patients with adenocarcinoma were extracted in the Hirosaki University Hospital and the Hirosaki National Hospital. IHC and ICC results showed a very high concordance rate: sensitivity of ICC in comparison with IHC was 85.7% (6/7), specificity was 100% (11/11), positive predictive value was 100% (6/6), and negative predictive value was 91.6% (11/12). Detection of ALK rearrangement using ICC on routine Papanicolau cytology slides is considered to be advantageous for lung cancer treatments.
- Published
- 2013
- Full Text
- View/download PDF
12. New method for quantitative assessment of airway calibre using a stereovision fibreoptic bronchoscope
- Author
-
Ken Okumura, J. Denpoya, Kazuyoshi Hirota, Takao Tsushima, Shingo Takanashi, and Akihito Hayashi
- Subjects
Male ,medicine.medical_specialty ,Computed tomography ,Fibreoptic bronchoscope ,Anesthesia, General ,Bronchoscopy ,medicine ,Quantitative assessment ,Fiber Optic Technology ,Humans ,Airway Management ,Aged ,Aged, 80 and over ,Measurement method ,Intraoperative Care ,medicine.diagnostic_test ,business.industry ,Equipment Design ,Middle Aged ,Airway Obstruction ,Bronchoscopes ,Anesthesiology and Pain Medicine ,Caliber ,Female ,Radiology ,Tomography, X-Ray Computed ,business ,Airway ,Nuclear medicine ,Surgical patients - Abstract
Background We have developed a new bronchoscopy system with two independent lenses at the tip of the device. This enables measurement of object size using the principle of triangulation. This study was performed to assess the accuracy of this system. Methods The accuracy of the bronchoscopy system was confirmed by measuring the diameters of four plastic tubes and 36 airway calibres in 12 surgical patients under general anaesthesia. The measured diameters of the tubes and airway tracts were compared with the manufactured diameters of tubes and those measured by high-resolution computed tomography (HRCT)-based virtual bronchoscopy, respectively. Results Using the new bronchoscope system, tube diameters, 9, 12, 15, and 19 mm, were measured as 9.9 (0.7), 12.8 (1.4), 16.3 (1.6), and 20.1 (2.0) mm, respectively. Airway calibres obtained by a stereovision bronchoscopy and HRCT-based virtual bronchoscopy were 8.66 (4.31) and 9.38 (5.09) mm, respectively. There is a significant correlation between airway calibres with the two measurement methods ( r =0.975, P Conclusions We have confirmed that this new bronchoscopy system could provide relatively accurate quantitative data. This new system may be useful in the clinic to measure airway dimension and lesion sizes such as tumours.
- Published
- 2012
- Full Text
- View/download PDF
13. Stress Assessment by Salivary Biomarkers in Patients with Lung Cancer Undergoing Chemotherapy
- Author
-
Hideaki Yamabe, Mayumi Urushizaka, Umi Kudo, Akihito Hayashi, Kumiko Kawasaki, Yuka Noto, Chieko Itaki, Maiko Kitajima, Shingo Takanashi, and Toshiko Tomisawa
- Subjects
Oncology ,Chemotherapy ,Stress assessment ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Cancer ,medicine.disease ,Profile of mood states ,Quality of life ,Internal medicine ,medicine ,Physical therapy ,In patient ,Lung cancer ,business ,Salivary biomarkers - Abstract
Background: It is important for medical staffs to understand the state of stress of patients with cancer. The authors investigated stress assessment in patients with lung cancer undergoing chemotherapy. Materials and Method: Salivary cortisol and α-amylase were measured as stress markers before and after chemotherapy in 10 patients. Emotional status was assessed using the Profile of Mood States (POMS) questionnaire, and Quality of Life (QOL) was assessed using the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire. Results: No significant differences were found between the before and after chemotherapy in salivary levels of cortisol or α-amylase, the POMS and QOL scores. The salivary cortisol levels correlated with the POMS subscales of anger-hostility, and confusion. A negative correlation was observed between the salivary cortisol level and the QOL full score. The FACT-L full score correlated with the POMS subscales of depression-dejection, fatigue, and confusion. Conclusions: Measurements of salivary stress markers are noninvasive and may be useful for assessing the stress state of the patients
- Published
- 2012
- Full Text
- View/download PDF
14. VERIFICATION ON ASBESTOS RELEASE DURING SURFACE PREPARATION OF DETERIORATED ASBESTOS CONTAINING CEMENT SHEETS
- Author
-
Masataka Tamura, Junko Koga, Akihito Hayashi, and Kenji Motohashi
- Subjects
Cement ,Waste management ,Surface preparation ,Architecture ,medicine ,Environmental science ,Building and Construction ,medicine.disease_cause ,Asbestos - Published
- 2012
- Full Text
- View/download PDF
15. Salivary Biomarkers May Be Useful to Assess Stress State in Patients with Lung Cancer Undergoing Chemotherapy
- Author
-
Akihito Hayashi, Yuka Noto, Shingo Takanashi, Hideaki Yamabe, Umi Kudo, Mayumi Urushizaka, Chieko Itaki, Kumiko Kawasaki, Maiko Kitajima, and Toshiko Tomisawa
- Subjects
Oncology ,medicine.medical_specialty ,Chemotherapy ,Saliva ,business.industry ,medicine.medical_treatment ,Cancer ,medicine.disease ,Profile of mood states ,Mood ,Quality of life ,Internal medicine ,Immunology ,medicine ,In patient ,Lung cancer ,business - Abstract
Objective: As it is important for medical staff to understand the stress state of patients with cancer, this study investigated the stress state in patients with lung cancer undergoing chemotherapy using salivary biomarkers and questionnaires. Materials and Methods: The subjects included 19 men and 9 women, with a mean age of 66.1 ± 7.1 years who received chemotherapy for lung cancer. Salivary samples of the participants were collected before and the 7 day after chemotherapy. Simultaneously, they completed the POMS (profile of mood states) and QOL (quality of life) questionnaires. The salivary cortisol and secretory IgA as stress markers were measured by enzyme immunoassay. Results: The salivary secretory IgA level was significantly higher at the 7th day after chemotherapy than before chemotherapy (p < 0.05), although the salivary cortisol level did not change. The tension-anxiety score, which is one of POMS subclasses, and total mood disturbance score were lower at day 7 of chemotherapy than before chemotherapy (p < 0.05), although no correlations were observed between POMS scores and salivary markers. However, a negative correlation was observed between the salivary cortisol level and the QOL full score (r= -0.411, p < 0.05). Conclusion: Measurement of salivary stress markers is noninvasive and may be useful for assessing the stress state of the patients.
- Published
- 2011
- Full Text
- View/download PDF
16. Heat Deterioration of Phospholipids. V. A New Rearrangement Reaction of Sugars and Phosphatidylethanolamine
- Author
-
Yoshihito Kasahara, Nobutoshi Hamaguchi, Hen-Sik Koh, Takehiko Tsuji, Yosuke Yokoyama, Akihito Hayashi, Shin-ichi Tebayashi, and Chul-Sa Kim
- Subjects
Reaction mechanism ,Hot Temperature ,Magnetic Resonance Spectroscopy ,Molecular Structure ,Phosphatidylethanolamines ,General Chemical Engineering ,Kornblum–DeLaMare rearrangement ,Carbohydrates ,General Medicine ,General Chemistry ,Sigmatropic reaction ,Medicinal chemistry ,chemistry.chemical_compound ,Maillard reaction ,symbols.namesake ,chemistry ,Amadori rearrangement ,Pyridine ,symbols ,Organic chemistry ,Rearrangement reaction ,Pyridinium - Abstract
Novel four 2,3-dihydro-1H-imidazo[1,2-a]pyridine-4-ylium derivatives were obtained with increase of UV absorption at 350 nm and browning of the solution by heating paste lecithin from soybean (SL) in octane. These four derivatives were formed by reaction of one molar of any sugar except 2-deoxysugars with two molar of phosphatidylethanolamines (PE) in SL. To confirm the reaction mechanism, several (13)C-labeled-sugars were reacted with 1,2-di-O-stearoyl-sn-glycero-3-phosphatidylethanolamine (DSPE), respectively. These reactants clearly showed that five carbons of the pyridinium ring and one carbon of the substituted group were based on those of a sugar and that the formation of the pyridinium derivatives was accompanied with cleaving between the carbons of 1- and 2-positions in the sugar and rearrangement. This reaction is a new rearrangement reaction and we named it "new pseudo Maillard rearrangement reaction".
- Published
- 2007
- Full Text
- View/download PDF
17. Heat Deterioration of Phospholipids. III. Thermally Deteriorated Products from Phosphatidylethanolamine and Hexose
- Author
-
Yoshihito Kasahara, Chul-Sa Kim, Akihito Hayashi, Ryoji Sono, Shin-ichi Tebayashi, Hen-Sik Koh, and Nobutoshi Hamaguchi
- Subjects
chemistry.chemical_classification ,Ethanol ,food.ingredient ,General Chemical Engineering ,General Medicine ,General Chemistry ,Lecithin ,Hexane ,chemistry.chemical_compound ,food ,chemistry ,Pyridine ,Browning ,Organic chemistry ,Hexose ,Raffinose ,Nuclear chemistry ,Octane - Abstract
Novel four 2,3-dihydro-1H-imidazo[1,2-a]pyridine-4-ylium derivatives were obtained with increase of UV absorption at 350 nm and browning of the solution by heating paste lecithin from soybean (SL) in octane. These four derivatives were characterized the factor based on UV absorption at 350 nm. The SL was separated into the hexane (DSSL fr.) and 60% ethanol in water frs. by liquid- liquid partition method. Even when the DSSL fr. was heated in octane more than 9 h, the four derivatives were not formed and increase of any UV absorption was also not observed but the solution color was slightly yellowing. On the other hand, the formation of four derivatives and increase of UV absorption at 350 nm were observed when DSSL and 60% ethanol in water frs. were combined and, then, heated in octane. From the 60% ethanol in water fr, sucrose, raffinose and stachyose were isolated and identified as compounds which involved the formation of the derivatives with the DSSL fr. When DSPE (1,2-di-O-stearoyl-sn-glycero-3-phosphatidylethanolamine) and any hexose were combined and then heated, two 2,3-dihydro-1H-imidazo[1,2-a]pyridine-4-ylium derivatives generated with increase of UV absorption at 350 nm and browning. From these results, it is concluded that the formation of derivatives, with increase of the UV absorption at 350 nm and browning, are based on the reaction of sugars and phosphatidylethanolamine (PE) in SL.
- Published
- 2006
- Full Text
- View/download PDF
18. Heat Deterioration of Phospholipids. IV. Thermally Deteriorated Products from Phosphatidylethanolamine and Several Sugars
- Author
-
Akihito Hayashi, Yoshihito Kasahara, Chul-Sa Kim, Hen-Sik Koh, Yosuke Yokoyama, Nobutoshi Hamaguchi, Shin-ichi Tebayashi, and Ryoji Sono
- Subjects
chemistry.chemical_classification ,General Chemical Engineering ,Pentose ,Heptose ,General Medicine ,General Chemistry ,Medicinal chemistry ,chemistry.chemical_compound ,chemistry ,Pyridine ,Browning ,Organic chemistry ,Moiety ,Hexose ,Pyridinium ,Octane - Abstract
Novel four 2,3-dihydro-1H-imidazo[1,2-a]pyridine-4-ylium derivatives were formed by reaction of PE and hexose or oligosaccharides including of hexose moiety in soybean lecithin with increase of UV absorption at 350 nm and browning of the solution. Therefore, several pentoses, a heptose and 2-deoxysugars besides hexoses were examined. When any pentose was reacted with PE in DSSL fr. in octane, two 2,3-dihydro-1H-imidazo[1,2-a]pyridine-4-ylium derivatives without a substitute at 6 position on the aromatic ring were formed with increase of UV absorption at 345nm and browning of the solution. On the other hand, two 2,3-dihydro-1H-imidazo[1,2-a]pyridine-4-ylium derivatives with 1,2-dihydroxyethyl group at 6 position on the ring were formed when a heptose was reacted with PE in DSSL fr. in octane. Contrary to these results, when 2-deoxysugars, regardless hexose or pentose, were reacted with PE in DSSL fr. in octane, the derivatives were not formed at all and change of UV absorption and browning in the solution could not also be observed. From these results, it is concluded that existence of an oxygen atom on 2 position of sugars is essential to brown, change the UV absorption, and form the pyridinium derivatives by heating and that rearrangement of carbon(s) in the sugar might involve the reaction of PE and sugars to form the pyridinium derivatives.
- Published
- 2006
- Full Text
- View/download PDF
19. Transforming growth factor β stimulates rheumatoid synovial fibroblasts via the type II receptor
- Author
-
Akihito Hayashi, Saburo Sone, Yanjmaa Bira, Yasuhiko Nishioka, Yutaka Nakaya, Junya Miyata, Kenji Tani, and Keiko Sato
- Subjects
medicine.medical_specialty ,business.industry ,Growth factor ,medicine.medical_treatment ,Connective tissue ,medicine.disease ,CTGF ,Pathogenesis ,medicine.anatomical_structure ,Endocrinology ,Rheumatology ,Internal medicine ,Rheumatoid arthritis ,Cancer research ,Medicine ,Receptor ,business ,Fibroblast ,Transforming growth factor - Abstract
Transforming growth factor (TGF)-beta regulates the function of fibroblasts, and has been shown to have a role in the pathogenesis of rheumatoid arthritis (RA) because several studies have demonstrated the presence of TGF-beta in the synovial tissue and synovial fluids of RA patients. In this study, we examined the expression of TGF-beta receptors in synovial fibroblasts of patients with RA and demonstrated the significance in functional responses of synovial fibroblasts to TGF-beta in this disorder. Transforming growth factor beta1 stimulated the expression of connective tissue growth factor (CTGF) in fibroblasts of patients with RA more than in those of patients with osteoarthritis (OA). Transforming growth factor beta1 induced the chemotactic migration of RA synovial fibroblasts and inhibited their proliferation significantly more than OA synovial fibroblasts. Both RA and OA synovial fibroblasts expressed detectable amounts of TGF-beta receptor type II mRNA, but the expression was higher in RA patients than in OA patients, as assessed by reverse transcriptase-polymerase chain reaction. There was no significant difference in the expression of TGF-beta receptor type I or type III in synovial fibroblasts between RA and OA patients. These results indicate that synovial fibroblasts of RA patients express the increased TGF-beta receptor type II, which is associated with altered responses to TGF-beta observed in CTGF expression, chemotaxis, and proliferation of RA synovial fibroblasts, and may have an important role in the pathogenesis of RA.
- Published
- 2005
- Full Text
- View/download PDF
20. The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases
- Author
-
Makoto Kimura, Akihito Hayashi, Keiko Sato, Junya Miyata, Shinsaku Otsuka, Kenji Tani, Tomoyuki Urata, and Saburo Sone
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,cathepsin B ,cathepsin G ,Cathepsin G ,cathepsin H ,Aminopeptidases ,General Biochemistry, Genetics and Molecular Biology ,Cathepsin B ,chemistry.chemical_compound ,Idiopathic pulmonary fibrosis ,Cathepsin H ,medicine ,Humans ,interstitial lung diseases ,Lymphocytes ,Aged ,Cathepsin ,aminopeptidase ,medicine.diagnostic_test ,business.industry ,General Medicine ,Middle Aged ,respiratory system ,medicine.disease ,Cathepsins ,thrombin ,respiratory tract diseases ,Bronchoalveolar lavage ,chemistry ,Case-Control Studies ,Immunology ,Female ,business ,Lung Diseases, Interstitial ,Bronchoalveolar Lavage Fluid ,Hypersensitivity pneumonitis ,Cryptogenic Organizing Pneumonia ,Peptide Hydrolases - Abstract
To determine the significance of proteases in interstitial lung diseases, we examined the activity of cathepsins, thrombin, and aminopeptidase in bronchoalveolar lavage (BAL) fluid from patients with these disorders. Significantly increased activities of cathepsin H and aminopeptidase were detected in BAL fluid from patients with idiopathic pulmonary fibrosis (IPF), cryptogenic organizing pneumonia (COP), chronic eosinophilic pneumonia (CEP) and hypersensitivity pneumonitis (HP). Significantly higher activity of cathepsin B was found in BAL fluid from patients with CEP. The activity of thrombin was significantly higher in patients with IPF and CEP. In patients with IPF, there were significant correlations between neutrophil number and the activity of cathepsin B, cathepsin H or aminopeptidase. In patients with COP and HP, the activity of the proteases was significantly higher in patients with higher number of lymphocytes than in those with lower number of lymphocytes. The present study suggests that the activity of the proteases is a useful marker in activity of the interstitial lung diseases, and may have a role in the pathogenesis of these disorders.
- Published
- 2005
21. Vascular Endothelial Growth Factor Level as a Prognostic Determinant of Small Cell Lung Cancer in Japanese Patients
- Author
-
Shingo Takanashi, Ken Okumura, Mika Kumagai, Akihito Hayashi, Takeshi Morimoto, Yukihiro Hasegawa, and Koichi Okudera
- Subjects
Male ,Vascular Endothelial Growth Factor A ,medicine.medical_specialty ,Pathology ,Lung Neoplasms ,Enolase ,Sensitivity and Specificity ,Gastroenterology ,chemistry.chemical_compound ,Japan ,Internal medicine ,Lactate dehydrogenase ,Internal Medicine ,Carcinoma ,Humans ,Medicine ,Clinical significance ,Platelet ,Carcinoma, Small Cell ,Survival analysis ,Aged ,L-Lactate Dehydrogenase ,Platelet Count ,business.industry ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Immunohistochemistry ,Survival Analysis ,respiratory tract diseases ,Vascular endothelial growth factor ,chemistry ,Multivariate Analysis ,Disease Progression ,Female ,business - Abstract
Objective To clarify the clinical significance of vascular endothelial growth factor (VEGF) in Japanese patients with small cell lung cancer (SCLC).Materials and Methods We measured serum VEGF levels using an enzyme-linked immunosorbent assay in 45 patients with SCLC before treatment and in 38 patients with benign pulmonary disease and in 32 healthy subjects (71 non-malignant subjects). VEGF immunostaining was performed in tissue biopsies obtained from 23 SCLC patients during bronchoscopic examination.Results Median serum VEGF level was 332 pg/ml in patients with SCLC and 160 pg/ml in non-malignant subjects, respectively. The 95% cut-off level to exclude non-malignant subjects was 500 pg/ml. An elevated VEGF level (>500 pg/ml) was found more frequently in patients with extensive disease of SCLC than in those with the limited disease (p
- Published
- 2005
- Full Text
- View/download PDF
22. P2.03a-054 A Single-Arm Phase II Study of Nab-Paclitaxel for Patients with Chemorefractory Non-Small Cell Lung Cancer
- Author
-
Hideo Yasugahira, Takeshi Morimoto, Hisashi Tanaka, Shingo Takanashi, Mika Kumagai, Akihito Hayashi, Kageaki Taima, Megumi Mikuniya, Yoshihito Tanaka, Masamichi Itoga, Sadatomo Tasaka, Koichi Okudera, and Kunihiko Nakamura
- Subjects
Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,business.industry ,Phases of clinical research ,medicine.disease ,Clinical trial ,Internal medicine ,medicine ,Non small cell ,Lung cancer ,business ,Nab-paclitaxel - Published
- 2017
- Full Text
- View/download PDF
23. Intratracheal Fire Ignited by a Gallium-Arsenide-Aluminum Diode Laser During Treatment of Airway Obstruction With Lung Cancer
- Author
-
Yukihiro Hasegawa, Masatoshi Muraoka, Hironori Ishihara, Mika Kumagai, Akihito Hayashi, Ken Okumura, Koichi Okudera, and Shingo Takanashi
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,business.industry ,Airway obstruction ,Laser ,medicine.disease ,law.invention ,Surgery ,Gallium arsenide ,chemistry.chemical_compound ,chemistry ,law ,medicine ,business ,Lung cancer - Published
- 2003
- Full Text
- View/download PDF
24. Examinations Of Impulse Oscillometry In The University Students With A History Of Bronchial Asthma
- Author
-
Kageaki Taima, Hisashi Tanaka, Ken Okumura, Akihito Hayashi, Shingo Takanashi, Yoshihito Tanaka, Takeshi Morimoto, and Junichi Dempoya
- Subjects
medicine.medical_specialty ,Pediatrics ,Impulse Oscillometry ,business.industry ,Physical therapy ,medicine ,business ,medicine.disease ,Asthma - Published
- 2012
- Full Text
- View/download PDF
25. Validation Of New Bronchoscope System With A Measuring Ability
- Author
-
Ken Okumura, Kazuyoshi Hirota, Takeshi Morimoto, Shingo Takanashi, Megumi Mikuniya, takao tushima, Akihito Hayashi, Jyunichi denpoya, and Kunihiko Nakamura
- Published
- 2010
- Full Text
- View/download PDF
26. [A case of adenocarcinoma of the lung with a long-term therapeutic effect due to S-1 administered as the sixth regimen]
- Author
-
Koichi, Okudera, Shingo, Takanashi, Akihito, Hayashi, Takeshi, Morimoto, Kunihiko, Nakamura, Megumi, Mikuniya, Junichi, Dempoya, and Ken, Okumura
- Subjects
Adult ,Male ,Antimetabolites, Antineoplastic ,Lung Neoplasms ,Antineoplastic Agents ,Gefitinib ,Docetaxel ,Adenocarcinoma ,Deoxycytidine ,Gemcitabine ,Carboplatin ,Drug Combinations ,Oxonic Acid ,Carcinoma, Non-Small-Cell Lung ,Antineoplastic Combined Chemotherapy Protocols ,Quinazolines ,Humans ,Taxoids ,Tegafur - Abstract
The patient was a 36-year-old male. He visited our department in February 2004 as a prior chest X-ray revealed multiple nodular shadows. After further examinations, he was diagnosed with stage IV adenocarcinoma of the lung. As treatment, 5 courses of carboplatin (CBDCA)+docetaxel (DOC), 3 courses of CBDCA+gemcitabine (GEM), 6 weeks of gefitinib, and 3 courses of GEM were administered. However, the tumor progressed, and S-1 (120 mg/day, 2 weeks on, 1 week off) was administered as the sixth regimen from May 2006. No severe side effects were observed, and an antitumor action was achieved over a relatively long period. Therefore, it was suggested that a single administration of S-1 for non-small cell lung cancer, which had been treated with other multiple regimens, is safe, and long-term control of the disease can be expected.
- Published
- 2009
27. Level of antibodies against mycobacterial glycolipid in the effusion for diagnosis of tuberculous pleural effusion
- Author
-
Shingo Takanashi, Yukihiro Hasegawa, Takeshi Morimoto, Ken Okumura, Akihito Hayashi, Kageaki Taima, Koichi Okudera, and Koji Fujimoto
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,Lipopolysaccharides ,Male ,Pathology ,medicine.medical_specialty ,Tuberculosis ,Pleural effusion ,Adenosine Deaminase ,Enzyme-Linked Immunosorbent Assay ,Antibodies ,Serology ,Pleural disease ,Interferon-gamma ,medicine ,Humans ,Lipoarabinomannan (LAM) ,Aged ,Aged, 80 and over ,Lipoarabinomannan ,Tuberculous pleural effusion ,Interferon-γ (IFN-γ) ,business.industry ,Respiratory disease ,Adenosine deaminase (ADA) ,Mycobacterium tuberculosis ,Tuberculosis, Pleural ,Middle Aged ,medicine.disease ,Pleural Effusion ,Effusion ,Pleurisy ,Female ,Glycolipids ,business ,Tuberculous glycolipid (TBGL) - Abstract
Summary Background Diagnosing tuberculous pleural effusion (pTB) is often difficult because the culturing of tubercle bacilli results in a negative test in the majority of cases. Serological tests for the detection of antibodies to tuberculous glycolipid (TBGL) and lipoarabinomannan (LAM) have been introduced for the diagnosis of pulmonary tuberculosis. We examined the levels of these antibodies, adenosine deaminase (ADA) and interferon- γ (IFN- γ ) in the pleural effusion and compared their diagnostic values in pTB. Methods We studied 65 patients with pleural effusion. Of those, 19 patients were diagnosed as having pTB according to our broad case definition. The etiologies in the other 46 patients were malignant effusion, transdative effusion and miscellaneous diseases. Determiner TBGL antibody ® (D-TBGL-Ab) and MycoDot ® were used for the detection of anti-LAM and anti-TBGL antibodies, respectively, in the pleural effusion. Results The sensitivity of ADA was 78.9% (15/19) and the specificity 97.8% (45/46). The sensitivity of IFN- γ was 84.2% (16/19) and the specificity 93.5% (43/46). The sensitivities of D-TBGL-Ab and MycoDot ® were both 52.6% (10/19) and their specificities were 95.7% (44/46) and 97.8% (45/46), respectively. When DTBGL-Ab (cutoff point: 2.0U/ml) and ADA activity (cutoff point: 57IU/l) were combined, the sensitivity was 94.7% (18/19) and the specificity 93.5% (43/46). Conclusions In the diagnosis of pTB, D-TBGL-Ab and MycoDot ® each have low sensitivity but high specificity. When D-TBGL-Ab is used in combination with ADA, the sensitivity and specificity are both >90%. We conclude that D-TBGL-Ab and ADA in combination are useful in the diagnosis of pTB.
- Published
- 2005
28. The long-term survival of a thymic carcinoma patient treated with S-1: a case report and literature review
- Author
-
Yoshihito Tanaka, Ken Okumura, Shingo Takanashi, Akihito Hayashi, Takeshi Morimoto, Kageaki Taima, Kunihiko Nakamura, Akira Kurose, and Hisashi Tanaka
- Subjects
Oncology ,Chemotherapy ,medicine.medical_specialty ,Pathology ,biology ,Systemic chemotherapy ,business.industry ,medicine.medical_treatment ,Case Report ,S-1 ,thymidylate synthase ,medicine.disease ,Thymidylate synthase ,Internal medicine ,Long term survival ,medicine ,Carcinoma ,biology.protein ,Neoplasm ,Pharmacology (medical) ,thymic carcinoma ,business ,Thymic carcinoma - Abstract
Background Thymic carcinoma is a rare neoplasm of the thymus. Systemic chemotherapy is an important therapeutic modality for thymic carcinoma. However, no standard chemotherapy for this carcinoma has yet been established. The usefulness of second-line or later-line chemotherapy has remained unclear. A case of relapsed thymic carcinoma that was successfully treated by S-1 as second-line chemotherapy is reported herein. Case presentation A 73-year-old man diagnosed as having thymic carcinoma was treated with three cycles of first-line chemotherapy with ADOC (cisplatin, doxorubicin, vincristine, and cyclophosphamide) and additional radiotherapy (50 Gy). Since his serum cytokeratin 19 fragment level increased suddenly after 3 months of stable disease, he was considered to have progressive disease, and was given S-1 as chemotherapy. Two months later, he had partial response, and the S-1 treatment has been continued since July 2009. Progression-free survival of greater than 4 years was obtained with S-1. Conclusion A case of relapsed thymic carcinoma that was treated with S-1, and continues to show a long progression-free survival with good quality of life on treatment is described. S-1 might be an active agent against relapsed thymic carcinoma.
- Published
- 2013
- Full Text
- View/download PDF
29. A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
- Author
-
Ken Okumura, Kageaki Taima, Hisashi Tanaka, Yoshihito Tanaka, Akihito Hayashi, Shingo Takanashi, Takeshi Morimoto, Michiko Shimada, and Akira Kurose
- Subjects
Oncology ,Adult ,Male ,Cancer Research ,medicine.medical_specialty ,EML4/ALK Fusion Gene ,Lung Neoplasms ,Oncogene Proteins, Fusion ,EGFR mutation ,medicine.drug_class ,EML4-ALK ,Case Report ,Adenocarcinoma ,medicine.disease_cause ,lcsh:RC254-282 ,Tyrosine-kinase inhibitor ,Internal medicine ,Genetics ,medicine ,Anaplastic lymphoma kinase ,Humans ,Epidermal growth factor receptor ,Lung cancer ,biology ,business.industry ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,respiratory tract diseases ,ErbB Receptors ,Erlotinib ,Mutation ,Cancer research ,biology.protein ,KRAS ,business ,medicine.drug - Abstract
Background Lung cancer is the leading cause of cancer-related death worldwide. Epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitor (TKI) is used for the patients with EGFR-mutant lung cancer. Recently, phase III studies in the patients with EGFR-mutant demonstrated that EGFR-TKI monotherapy improved progression-free survival compared with platinum-doublet chemotherapy. The echinoderm microtubule-associated protein-like 4 (EML4) - anaplastic lymphoma kinase (ALK) fusion oncogene represents one of the newest molecular targets in non-small cell lung cancer (NSCLC). Patients who harbor EML4-ALK fusions have been associated with a lack of EGFR or KRAS mutations. Case presentation We report a 39-year-old patient diagnosed as adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene. We treated this patient with erlotinib as the third line therapy, but no clinical benefit was obtained. Conclusion We experienced a rare case with EGFR mutation and EML4-ALK. Any clinical benefit using EGFR-TKI was not obtained in our case. The therapeutic choice for the patients with more than one driver mutations is unclear. We needs further understanding of the lung cancer molecular biology and the biomarker infomation.
- Published
- 2012
30. A phase I/II study of gemcitabine (GEM) and carboplatin (CBDCA) biweekly combination chemotherapy for inoperable stage IIIB, IV non-small-cell lung cancer (NSCLC) (final report)
- Author
-
Akihito Hayashi, Hideyuki Nakagawa, Ken Okumura, Yukihiro Hasegawa, Shingo Takanashi, Koichi Okudera, Kageaki Taima, and T. Morimoto
- Subjects
Oncology ,Cancer Research ,Schedule ,medicine.medical_specialty ,endocrine system diseases ,business.industry ,non-small cell lung cancer (NSCLC) ,Combination chemotherapy ,Stage iiib ,medicine.disease ,Gemcitabine ,Carboplatin ,respiratory tract diseases ,chemistry.chemical_compound ,Phase i ii ,chemistry ,Internal medicine ,Maximum tolerated dose ,medicine ,business ,neoplasms ,medicine.drug - Abstract
7333 Background: The purpose of this study was to determine maximum tolerated dose (MTD) of a combination of GEM plus CBDCA administration on a biweekly schedule for inoperable NSCLC, and to assess...
- Published
- 2005
- Full Text
- View/download PDF
31. A phase I study of biweekly combination chemotherapy with gemcitabine (GEM) and carboplatin (CBDCA) for inoperable stages IIIB and IV non-small-cell lung cancer (NSCLC)
- Author
-
Akihito Hayashi, Ken Okumura, Shingo Takanashi, M. Kumagai, Koichi Okudera, Yukihiro Hasegawa, Hideyuki Nakagawa, T. Morimoto, and Kageaki Taima
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,business.industry ,non-small cell lung cancer (NSCLC) ,Combination chemotherapy ,medicine.disease ,Carboplatin ,Gemcitabine ,Phase i study ,chemistry.chemical_compound ,chemistry ,Internal medicine ,Maximum tolerated dose ,Toxicity ,medicine ,business ,therapeutics ,neoplasms ,medicine.drug - Abstract
7237 Background: The purpose of this study was to determine maximum tolerated dose (MTD) and the dose-limiting toxicity (DLT) of a combination of gemcitabine plus carboplatin administration in a bi...
- Published
- 2004
- Full Text
- View/download PDF
32. 340 Evaluation of Spiral Uneven Artifact in Double Thresholded Shaded Surface Display
- Author
-
Yoshinori Taniguchi, Michihiro Yamaguchi, and Akihito Hayashi
- Subjects
Artifact (error) ,Computer science ,business.industry ,Computer graphics (images) ,Computer vision ,General Medicine ,Artificial intelligence ,business ,Surface display ,Spiral - Published
- 1995
- Full Text
- View/download PDF
33. Catalytic gasification of carbon: Method for the determination of the activity of alkali metal catalysts in the gasification of highly pure amorphous and graphitic carbons with steam
- Author
-
Keikichi Fujikawa, Akihito Hayashi, Takaji Kanazuka, Hirotoshi Tanaka, Takuro Kodera, and Toru Kanno
- Subjects
Metal ,Amorphous carbon ,Chemistry ,visual_art ,Inorganic chemistry ,General Engineering ,visual_art.visual_art_medium ,Graphite ,Activation energy ,Alkali metal ,Dissolution ,Catalysis ,Amorphous solid - Abstract
Gasifications of highly pure carbons in an amorphous state and graphite were studied in the presence of alkali metal catalysts and water. A detailed investigation was made with respect to the dispersion processes of the catalysts. It was found that (i) evaporation of the metal, (ii) condensation of the metal vapour into the amorphous carbon and (iii) dissolution of alkali metal into glass-wool occurred under the conditions of the gasification. Under certain conditions that minimized such dispersion phenomena during the gasification, both the gasification ratt and the amount of the effective catalyst were measured simultaneously. The order of the catalytic activity per unit catalyst composition and unit surface area of carbon was determined as follows: Li>Cs>Rb≥K>Na. A mechanism controlling such catalytic activity is discussed on the basis of the mediator action and the role of the carbon activator of the catalyst.
- Published
- 1989
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.